Varex Imaging Corp Designs, manufactures, sells, and services X-ray imaging components, including X-ray tubes, detectors, ionization chambers, high-voltage connectors, software, collimators, generators, exposure control devices, and heat exchangers.. The company operates through two segments: Medical, the key revenue driver, providing X-ray imaging components and accessories for healthcare applications, and Industrial, which provides Linatron X-ray accelerators, X-ray tubes, flat panel detectors, high-voltage connectors, and coolers for non-medical use. Geographically, it generates the majority of its revenue from Europe, the Middle East, and Africa (EMEA), with the rest coming from the Americas and Asia Pacific.
2016
2.4K+
LTM Revenue $849M
LTM EBITDA $121M
$719M
Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.
As of November 2025, Varex Imaging reported last 12-month revenue of $849M and EBITDA of $121M.
In the same period, Varex Imaging generated $290M in LTM gross profit and -$52.0M in net income.
See Varex Imaging valuation multiples based on analyst estimatesIn the most recent fiscal year, Varex Imaging reported revenue of $845M and EBITDA of $0.7M.
Varex Imaging expects next 12-month revenue of XXX   and NTM EBITDA of XXX
See Varex Imaging valuation multiples based on analyst estimates| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue | $849M | XXX | $845M | XXX | XXX | XXX |
| Gross Profit | $290M | XXX | $291M | XXX | XXX | XXX |
| Gross Margin | 34% | XXX | 34% | XXX | XXX | XXX |
| EBITDA | $121M | XXX | $0.7M | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 0% | XXX | XXX | XXX |
| EBIT | -$9.4M | XXX | $66.1M | XXX | XXX | XXX |
| EBIT Margin | -1% | XXX | 8% | XXX | XXX | XXX |
| Net Profit | -$52.0M | XXX | -$70.3M | XXX | XXX | XXX |
| Net Margin | -6% | XXX | -8% | XXX | XXX | XXX |
| Net Debt | XXX | XXX | $223M | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Varex Imaging has current market cap of $478M, and EV of $719M.
As of December 5, 2025, Varex Imaging's stock price is $11.
See Varex Imaging trading valuation data| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $719M | $478M | XXX | XXX | XXX | XXX | $0.89 |
Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more
Start Free TrialVarex Imaging's trades at 0.9x EV/Revenue multiple, and 15.2x EV/EBITDA.
See valuation multiples for Varex Imaging and 15K+ public compsAs of December 5, 2025, Varex Imaging has market cap of $478M and EV of $719M.
Equity research analysts estimate Varex Imaging's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Varex Imaging has a P/E ratio of -9.2x.
| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $478M | XXX | $478M | XXX | XXX | XXX |
| EV (current) | $719M | XXX | $719M | XXX | XXX | XXX |
| EV/Revenue | 0.8x | XXX | 0.9x | XXX | XXX | XXX |
| EV/EBITDA | 5.9x | XXX | 15.2x | XXX | XXX | XXX |
| EV/EBIT | -76.1x | XXX | 17.7x | XXX | XXX | XXX |
| EV/Gross Profit | 2.5x | XXX | n/a | XXX | XXX | XXX |
| P/E | -9.2x | XXX | -9.0x | XXX | XXX | XXX |
| EV/FCF | n/a | XXX | 35.9x | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.
Start Free TrialVarex Imaging's last 12 month revenue growth is 3%
Varex Imaging's revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.1M for the same period.
Varex Imaging's rule of 40 is 9% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
Varex Imaging's rule of X is 22% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
See operational valuation multiples for Varex Imaging and other 15K+ public comps| LTM | NTM | Last FY | FY 2025 | FY 2026 | FY 2027 | |
|---|---|---|---|---|---|---|
| Revenue Growth | 3% | XXX | 3% | XXX | XXX | XXX |
| EBITDA Margin | 14% | XXX | 6% | XXX | XXX | XXX |
| EBITDA Growth | -2% | XXX | 59% | XXX | XXX | XXX |
| Rule of 40 | 9% | XXX | 9% | XXX | XXX | XXX |
| Bessemer Rule of X | XXX | XXX | 22% | XXX | XXX | XXX |
| Revenue per Employee | XXX | XXX | $0.4M | XXX | XXX | XXX |
| Opex per Employee | XXX | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| G&A Expenses to Revenue | XXX | XXX | n/a | XXX | XXX | XXX |
| R&D Expenses to Revenue | XXX | XXX | 11% | XXX | XXX | XXX |
| Opex to Revenue | XXX | XXX | 27% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| 2025E | 2026E | 2027E | 2025E | 2026E | 2027E | |
| Philips | XXX | XXX | XXX | XXX | XXX | XXX |
| Perspective Therapeutics | XXX | XXX | XXX | XXX | XXX | XXX |
| SmartVest | XXX | XXX | XXX | XXX | XXX | XXX |
| InfuSystem | XXX | XXX | XXX | XXX | XXX | XXX |
| Myomo | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Varex Imaging acquired XXX companies to date.
Last acquisition by Varex Imaging was XXXXXXXX, XXXXX XXXXX XXXXXX . Varex Imaging acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX ).
See M&A valuation multiples| Acquired Company | EV | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXX | XXX | XXX | XXX |
Sign up to see revenue and EBITDA valuation multiples for 65K+ M&A deals.
Start Free Trial| When was Varex Imaging founded? | Varex Imaging was founded in 2016. |
| Where is Varex Imaging headquartered? | Varex Imaging is headquartered in United States of America. |
| How many employees does Varex Imaging have? | As of today, Varex Imaging has 2.4K+ employees. |
| Who is the CEO of Varex Imaging? | Varex Imaging's CEO is Mr. Sunny S. Sanyal. |
| Is Varex Imaging publicy listed? | Yes, Varex Imaging is a public company listed on NAS. |
| What is the stock symbol of Varex Imaging? | Varex Imaging trades under VREX ticker. |
| When did Varex Imaging go public? | Varex Imaging went public in 2017. |
| Who are competitors of Varex Imaging? | Similar companies to Varex Imaging include e.g. Philips, Perspective Therapeutics, SmartVest, InfuSystem. |
| What is the current market cap of Varex Imaging? | Varex Imaging's current market cap is $478M |
| What is the current revenue of Varex Imaging? | Varex Imaging's last 12 months revenue is $849M. |
| What is the current revenue growth of Varex Imaging? | Varex Imaging revenue growth (NTM/LTM) is 3%. |
| What is the current EV/Revenue multiple of Varex Imaging? | Current revenue multiple of Varex Imaging is 0.8x. |
| Is Varex Imaging profitable? | Yes, Varex Imaging is EBITDA-positive (as of the last 12 months). |
| What is the current EBITDA of Varex Imaging? | Varex Imaging's last 12 months EBITDA is $121M. |
| What is Varex Imaging's EBITDA margin? | Varex Imaging's last 12 months EBITDA margin is 14%. |
| What is the current EV/EBITDA multiple of Varex Imaging? | Current EBITDA multiple of Varex Imaging is 5.9x. |
Get access to always up-to-date, precisely categorized 70K+ public and private valuation multiples, across tech and beyond.